ClearPoint Neuro
CLPT
118 hedge funds and large institutions have $118M invested in ClearPoint Neuro in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 25 closing their positions.
115% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 20
87% more call options, than puts
Call options by funds: $4.5M | Put options by funds: $2.41M
12% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 25
3.97% more ownership
Funds ownership: 39.83% → 43.8% (+4%)
0% more funds holding
Funds holding: 118 → 118 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less capital invested
Capital invested by funds: $155M → $118M (-$36.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCO
MAK Capital One
New York
|
+$24M |
| 2 |
SG Americas Securities
New York
|
+$4.7M |
| 3 |
Goldman Sachs
New York
|
+$2.19M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$1.98M |
| 5 |
LG
Lane Generational
Dover,
Massachusetts
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Stempoint Capital
New York
|
-$6.59M |
| 2 |
Millennium Management
New York
|
-$3.58M |
| 3 |
FCM
FirstWave Capital Management
Miami,
Florida
|
-$3.38M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.97M |
| 5 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$2.47M |
CLPT Hedge Fund Activity: Q1 2026 in Review
118 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q1 2026, worth a combined $118M — down 24% from $155M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CLPT positions and 25 closed out — a net gain of 3 holders — while 43 added to existing stakes and 20 trimmed.
The largest buyer was MAK Capital One, opening a new position worth an estimated $24M. The largest seller was Stempoint Capital, exiting entirely with an estimated $6.59M sold.
- 118 institutional investors held ClearPoint Neuro (CLPT) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $118M of ClearPoint Neuro stock for Q1 2026, down 24% quarter-over-quarter.
- 28 funds opened new ClearPoint Neuro positions in Q1 2026 and 25 closed out, a net change of +3 holders.
- The largest ClearPoint Neuro buyer in Q1 2026 was MAK Capital One, an estimated $24M added.
- The largest ClearPoint Neuro seller in Q1 2026 was Stempoint Capital, an estimated $6.59M sold.
Based on aggregated 13F filings for Q1 2026.